ERVW-1 and infection: Additional structural analysis of intermediate complexes, e.g., at time points 12 and 24 months post-infection, in combination with mutagenesis studies will be necessary to fully understand the roles of Ab and Env mutations in the divergence points of antibody evolution and acquisition of breadth.